David Meriwether
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Clinical Biochemistry top 5%
Papers in
-
- Sphingolipid Metabolism and Signaling 3
- Peroxisome Proliferator-Activated Receptors 2
- Surgery 8
- Cholesterol and Lipid Metabolism 7
- Co-authors
- Srinivasa T. Reddy (34 shared papers)Alan M. Fogelman (20 shared papers)Mohamad Navab (14 shared papers)Víctor Grijalva (17 shared papers)Feng Su (7 shared papers)Robin Farias‐Eisner (7 shared papers)A. Chattopadhyay (9 shared papers)Christina Charles‐Schoeman (5 shared papers)
- Journals
- Journal of Lipid Research (8 papers)Circulation (2 papers)Circulation Research (2 papers)Nutrition Metabolism and Cardiovascular Diseases (2 papers)Cellular and Molecular Gastroenterology and Hepatology (2 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
David Meriwether
37 papers receiving 934 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 212
- Clinical Biochemistry 68
- Endocrinology, Diabetes and Metabolism 133
- Surgery 265
- Biochemistry 48
Countries citing papers authored by David Meriwether
This map shows the geographic impact of David Meriwether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meriwether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meriwether more than expected).
Fields of papers citing papers by David Meriwether
This network shows the impact of papers produced by David Meriwether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meriwether. The network helps show where David Meriwether may publish in the future.
Co-authors
The 25 scholars most cited alongside David Meriwether, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 76 | |
| 2 | 2013 | 75 | |
| 3 | 2019 | 71 | |
| 4 | 2011 | 69 | |
| 5 | 2011 | 62 | |
| 6 | 2012 | 61 | |
| 7 | 2013 | 59 | |
| 8 | 2011 | 58 | |
| 9 | 2015 | 42 | |
| 10 | 2014 | 39 | |
| 11 | 2011 | 37 | |
| 12 | 2017 | 35 | |
| 13 | 2022 | 32 | |
| 14 | 2012 | 30 | |
| 15 | 2021 | 25 | |
| 16 | 2012 | 23 | |
| 17 | 2021 | 21 | |
| 18 | 2016 | 20 | |
| 19 | 2011 | 15 | |
| 20 | 2018 | 14 |
About David Meriwether
David Meriwether is a scholar working on Molecular Biology, Surgery, Clinical Biochemistry, Pharmacology and Epidemiology, having authored 39 papers that have together received 945 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (7 papers), Paraoxonase enzyme and polymorphisms (6 papers), Inflammatory mediators and NSAID effects (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Cancer, Lipids, and Metabolism (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Cancer Research (212 citations), Clinical Biochemistry (68 citations), Endocrinology, Diabetes and Metabolism (133 citations), Surgery (265 citations) and Biochemistry (48 citations). David Meriwether has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Srinivasa T. Reddy, Alan M. Fogelman, Mohamad Navab, Víctor Grijalva, Feng Su, Robin Farias‐Eisner, A. Chattopadhyay, Christina Charles‐Schoeman, Satoshi Imaizumi and Ekambaram Ganapathy. Their work appears in journals such as Journal of Lipid Research, Circulation, Circulation Research, Nutrition Metabolism and Cardiovascular Diseases and Cellular and Molecular Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.